TOP 10 - Oncologia de Precisão

Programação

8h - Artigo 1: Delivering precision oncology to patients with cancer. Mateo, J. Nature Medicine 2022; 28:658
Dr. Ricardo Caponero 

8h20 - Artigo 2: Moving the Needle on Precision Medicine in Pancreatic Cancer. O'Kane, G. J Clin Oncol 2022; 40(24):2693
Dra.Emili Ayoub 

8h40 - Artigo 3:  Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer. Gale, D. Ann Oncol 2022; 33(5):500
Dr. Marcos André

9h - Artigo 4: Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer (PROPEL). Clarke, N. NEJM Evid 2022; 1:9
Dr. Ariel Kann 

9h20 - Artigo 5:  Genomics to select treatment for patients with metastatic breast cancer (Safir02). Andre, F. Nature 2022: 610(7931):343
Dr. Pedro Exman

9h40 - Artigo 6: Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. Modi, S. N Engl J Med 2022; 387:9
Dra. Taciana Mutão

10-10h40 - INTERVALO

10h40 - Artigo 7: TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel—Overall survival after median follow-up of 3 years (ANZUP 1603). Hofman, M. J Clin Oncol 2022; 40(16):5000
Dra. Elisa Ricardo

11h - Artigo 8: Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study. Bernstam, F. Cancer Discov 2022; 12(2):402
Dr. Thiago Jorge 

11h20 - Artigo 9: Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial. Subbiah, V. Lancet Oncol 2022; 23(1): 53
Dr. Jefferson Pimenta 

11h40 - Artigo 10: Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns. Lee, J. JCO Precis Oncol 2021; 5:1354
Dr. Cheng Tzu 

12h - Encerramento